Using BestKeeper software, GAPDH, PUM1, and RPN1 were identified as the most suitable reference gene among 20 rectal tumor cases irrespective of their stage II-IV, pathology, and treatment regime, whereas B2M showed the least stable expression among the studied potential reference genes for rectal tumor. This evidence concerns the gene RPN1 and rectal neoplasm.